Biznesradar bez reklam? Sprawdź BR Plus
Branża Produkcja leków
Stopy zwrotu
| Profil | 1t | 1m | 3m | 6m | YTD | 12m | 24m | 36m | 60m | 120m |
|---|---|---|---|---|---|---|---|---|---|---|
| BAY (BAYER) | -8,84% | -7,65% | -12,71% | +0,19% | -5,86% | +34,97% | +18,44% | bd. | bd. | bd. |
| BGD (BIOGENED) | -2,15% | -5,70% | -4,71% | -14,95% | -15,74% | -30,98% | -8,80% | +42,67% | +64,95% | +57,11% |
| BIO (BIOTON) | -2,20% | -4,07% | -3,14% | -0,74% | +3,89% | -5,42% | +15,40% | +10,16% | -22,59% | -57,70% |
| CLN (CLNPHARMA) | +0,98% | -3,29% | -3,74% | -1,67% | +1,23% | -5,50% | +33,07% | +32,05% | -53,38% | bd. |
| CRM (CORMAY) | -1,82% | -7,24% | +44,24% | +40,10% | +43,09% | -0,37% | -7,24% | -27,10% | -54,98% | -74,50% |
| KRK (KRKA) | +1,11% | +4,39% | +11,86% | +28,71% | +27,21% | +42,80% | +103,65% | +149,73% | +201,51% | +600,13% |
| LILY (ELILILLY) | 0,00% | +18,16% | bd. | bd. | bd. | bd. | bd. | bd. | bd. | bd. |
| MAB (MABION) | -2,93% | -3,83% | -9,44% | -10,55% | +4,44% | -24,38% | -58,95% | -59,25% | -90,65% | -90,22% |
| NVO (NVONORDSK) | -8,19% | -7,99% | +3,84% | -10,26% | -24,25% | -45,90% | bd. | bd. | bd. | bd. |
| PHR (PHARMENA) | -3,05% | -7,56% | -9,66% | +4,26% | +22,31% | -10,67% | -48,04% | -49,86% | -63,52% | -81,42% |
| SPH (SOPHARMA) | +6,61% | +0,25% | +6,05% | -35,78% | -35,78% | -46,64% | -34,92% | -22,16% | +29,26% | +96,16% |
| SVE (SNTVERSE) | -3,75% | -15,25% | -25,14% | -30,18% | -26,16% | -47,16% | -46,10% | -50,69% | -72,91% | +89,79% |
Biznesradar bez reklam? Sprawdź BR Plus